Literature DB >> 7513070

Expression of cytokines in brain lesions in subacute sclerosing panencephalitis.

I Nagano1, S Nakamura, M Yoshioka, J Onodera, K Kogure, Y Itoyama.   

Abstract

We analyzed frozen brain specimens from three patients with subacute sclerosing panencephalitis (SSPE) for the presence of interleukin (IL)-1 beta, IL-2, IL-6, tumor necrosis factor (TNF), lymphotoxin (LT), and interferon (IFN)-gamma using immunocytochemical techniques. We detected these cytokines in SSPE brain lesions demonstrating extensive cellular infiltrates, demyelination, and gliosis. Double-label immunocytochemistry, using cell-specific markers, showed that positive immunoreactivity for these cytokines was present on both infiltrating cells and resident brain cells. We also found IL-6, TNF, and IFN-gamma at lower levels in brain tissue from a patient with progressive multifocal leukoencephalopathy. In contrast, normal control brain sections showed no reactivity for any of the cytokines. These findings indicate that IL-1 beta, IL-2, IL-6, TNT, LT, and IFN-gamma may be produced in SSPE lesions and may be involved in the lesion pathogenesis of SSPE.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7513070     DOI: 10.1212/wnl.44.4.710

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  11 in total

1.  A role for surface lymphotoxin in experimental autoimmune encephalomyelitis independent of LIGHT.

Authors:  Jennifer L Gommerman; Keith Giza; Stuart Perper; Irene Sizing; Apinya Ngam-Ek; Cheryl Nickerson-Nutter; Jeffrey L Browning
Journal:  J Clin Invest       Date:  2003-09       Impact factor: 14.808

2.  Role for tumor necrosis factor-α in JC virus reactivation and progressive multifocal leukoencephalopathy.

Authors:  Hassen S Wollebo; Mahmut Safak; Luis Del Valle; Kamel Khalili; Martyn K White
Journal:  J Neuroimmunol       Date:  2010-12-24       Impact factor: 3.478

3.  Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.

Authors:  Kate Manley; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  Virology       Date:  2007-06-06       Impact factor: 3.616

4.  Infection of neonatal mice with sindbis virus results in a systemic inflammatory response syndrome.

Authors:  W B Klimstra; K D Ryman; K A Bernard; K B Nguyen; C A Biron; R E Johnston
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

5.  NFAT4 is required for JC virus infection of glial cells.

Authors:  Kate Manley; Bethany A O'hara; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  J Virol       Date:  2006-10-11       Impact factor: 5.103

6.  Indoleamine 2,3-dioxygenase mediates cell type-specific anti-measles virus activity of gamma interferon.

Authors:  Karola Obojes; Oliver Andres; Kwang Sik Kim; Walter Däubener; Jürgen Schneider-Schaulies
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

7.  Interleukin (IL)-12, IL-2, interferon-gamma gene polymorphisms in subacute sclerosing panencephalitis patients.

Authors:  Vuslat Yilmaz; Veysi Demirbilek; Candan Gürses; Sibel P Yentür; Serap Uysal; Zuhal Yapici; Gülden Yilmaz; Aaron Muncey; Ozlem Cokar; Emel Onal; Aysen Gökyiğit; Güher Saruhan-Direskeneli
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

8.  Active interleukin-1 receptor required for maximal progression of acute pancreatitis.

Authors:  J G Norman; G Fink; M Franz; J Guffey; G Carter; B Davison; C Sexton; M Glaccum
Journal:  Ann Surg       Date:  1996-02       Impact factor: 12.969

Review 9.  Viral induced demyelination.

Authors:  S A Stohlman; D R Hinton
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

Review 10.  New insights on human polyomavirus JC and pathogenesis of progressive multifocal leukoencephalopathy.

Authors:  Anna Bellizzi; Elena Anzivino; Donatella Maria Rodio; Anna Teresa Palamara; Lucia Nencioni; Valeria Pietropaolo
Journal:  Clin Dev Immunol       Date:  2013-04-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.